المؤلفون: Scully, Marie¹ m.scully@ucl.ac.uk, Antun, Ana², Cataland, Spero R.³, Coppo, Paul⁴, Dossier, Claire⁵, Biebuyck, Nathalie⁶, Hassenpflug, Wolf-Achim⁷, Kentouche, Karim⁸, Knöbl, Paul⁹, Kremer Hovinga, Johanna A.¹⁰, López-Fernández, M. Fernanda¹¹, Matsumoto, Masanori¹², Ortel, Thomas L.¹³, Windyga, Jerzy¹⁴, Bhattacharya, Indranil¹⁵, Cronin, Michael¹⁵, Hong Li¹⁵, Mellgård, Björn¹⁵, Patel, Munjal¹⁵, Patwari, Parth¹⁵

المصدر: New England Journal of Medicine. 5/2/2024, Vol. 390 Issue 17, p1584-1596. 13p.

مصطلحات موضوعية: *THROMBOTIC thrombocytopenic purpura, *CROSSOVER trials

المؤلفون: Scully, Marie¹ m.scully@ucl.ac.uk, Antun, Ana², Cataland, Spero R.³, Coppo, Paul⁴, Dossier, Claire⁵, Biebuyck, Nathalie⁶, Hassenpflug, Wolf-Achim⁷, Kentouche, Karim⁸, Knöbl, Paul⁹, Hovinga, Johanna A. Kremer¹⁰, López-Fernández, M. Fernanda¹¹, Matsumoto, Masanori¹², Ortel, Thomas L.¹³, Windyga, Jerzy¹⁴, Bhattacharya, Indranil¹⁵, Cronin, Michael¹⁵, Hong Li¹⁵, Mellgård, Björn¹⁵, Patel, Munjal¹⁵, Patwari, Parth¹⁵

المصدر: New England Journal of Medicine. 4/2/2024, Vol. 390 Issue 17, p1584-1596. 13p.

مصطلحات موضوعية: *THROMBOTIC thrombocytopenic purpura, *CROSSOVER trials

المؤلفون: Chander, Deepak P.¹, Loch, Michelle M.¹, Cataland, Spero R.², George, James N.³ james-george@ouhsc.edu

المصدر: New England Journal of Medicine. Jul2019, Vol. 381 Issue 1, p92-94. 3p.

مصطلحات موضوعية: *THROMBOTIC thrombocytopenic purpura, *BLOOD coagulation factor VIII, *JEHOVAH'S Witnesses

المؤلفون: Scully, M.¹, Cataland, S. R.², Peyvandi, F.³, Coppo, P.⁴, Knöbl, P.⁵, Hovinga, J. A. Kremer⁶, Metjian, A.⁷, de la Rubia, J.⁸, Pavenski, K.⁹, Callewaert, F.¹⁰, Biswas, D.¹⁰, De Winter, H.¹⁰, Zeldin, R. K.¹⁰ hilde.dewinter@ablynx.com, Scully, Marie¹¹, Cataland, Spero R¹¹, Peyvandi, Flora¹¹, Coppo, Paul¹¹, Knöbl, Paul¹¹, Kremer Hovinga, Johanna A¹¹, Metjian, Ara¹¹

المصدر: New England Journal of Medicine. 1/24/2019, Vol. 380 Issue 4, p335-346. 12p.

مصطلحات موضوعية: *THERAPEUTIC use of immunoglobulins, *THROMBOTIC thrombocytopenic purpura treatment, *FIBRINOLYTIC agents, *BLOOD coagulation factors, *COMPARATIVE studies, *GINGIVAL hyperplasia, *HEMORRHAGE, *IMMUNOGLOBULINS, *RESEARCH methodology, *MEDICAL cooperation, *PLASMA exchange (Therapeutics), *RESEARCH, *THROMBOTIC thrombocytopenic purpura, *EVALUATION research, *BODY mass index, *RANDOMIZED controlled trials, *BLIND experiment, *PLATELET count, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents

المؤلفون: Peyvandi, Flora^1,2, Scully, Marie^3,4, Hovinga, Johanna A. Kremer^5,6, Cataland, Spero⁷, Knöbl, Paul⁸, Haifeng Wu⁹, Artoni, Andrea¹, Westwood, John-Paul³, Taleghani, Magnus Mansouri^5,6, Jilma, Bernd¹⁰, Callewaert, Filip¹¹ filip.callewaert@ablynx.com, Ulrichts, Hans¹², Duby, Christian¹¹, Tersago, Dominique¹¹, Kremer Hovinga, Johanna A (AUTHOR), Wu, Haifeng (AUTHOR), Mansouri Taleghani, Magnus (AUTHOR), TITAN Investigators (CORPORATE AUTHOR)

المصدر: New England Journal of Medicine. 2/11/2016, Vol. 374 Issue 6, p511-522. 12p.

مصطلحات موضوعية: *THERAPEUTIC use of immunoglobulins, *THROMBOTIC thrombocytopenic purpura treatment, *BLOOD platelet aggregation, *PLASMA exchange (Therapeutics), *TREATMENT effectiveness, *FIBRINOLYTIC agents, *BLOOD coagulation factors, *COMPARATIVE studies, *GLYCOPROTEINS, *HEMORRHAGE, *IMMUNOGLOBULINS, *RESEARCH methodology, *MEDICAL cooperation, *RESEARCH, *RESEARCH funding, *THROMBOTIC thrombocytopenic purpura, *DISEASE relapse, *EVALUATION research, *RANDOMIZED controlled trials, *DISEASE remission, *BLIND experiment, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents